As part of the highly acclaimed SGLT2 educational programme, Professor Cliff Bailey will report back from EASD and ADA in October 2021 with all the latest news and data around SGLT2 inhibitors. This will be a short 30 minute webinar including time for you to pose your questions to the expert.
This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant
